NICE guidance 'Suspected Cancer: Recognition and Referral' (NG12) was published on 22 June 2015. This updated and replaced the previous NICE clinical guideline (CG27) published June 2005. The 2015 full guidance can be accessed at the following link, and you can navigate this by cancer site to symptom(s): http://nice.org.uk/guidance/ng12
The Y&H GP Leads group have produced a briefing document as a high level overview of the new guidance, with some more specific points for the attention of providers and commissioners, and GPs in relation to cancer sites where there have been more significant changes to the guidance e.g. lowering the age threshold for referral.
Further work has been undertaken by the Y&H GP Leads group to define referral criteria for different cancer sites, being mindful that additional work will be required to reflect local pathways, IT systems and administrative processes in each locality. The purpose of this work is to encourage best practice referral pathways in line with the most up to date guidance, and to avoid duplication of effort in localities where possible. The outputs of this work can be found below, and should be read alongside the guidance notes also listed below.
If you have any questions about this work, please contact email@example.com
join our mailing list
As the 3 Cancer Alliances in Yorkshire & Humber are now well established, with their own communication channels & social media, the Clinical Network has decided to close the Y&H Cancer twitter account. Twitter accounts to now follow are @HCV_STP @WYHpartnership @SYBhealthcare.